DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY

被引：124
|
作者：
OVERWEG, J
BINNIE, CD
MEIJER, JWA
MEINARDI, H
NUIJTEN, STM
SCHMALTZ, S
WAUQUIER, A
机构：
[1] JANSSEN PHARMACEUT,B-2340 BEERSE,BELGIUM
[2] EPILEPSY CTR,DETROIT,MI
来源：
EPILEPSIA | 1984年 / 25卷 / 02期
关键词：
D O I：
10.1111/j.1528-1157.1984.tb04178.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：217 / 222
页数：6
相关论文
共 50 条
  • [21] A PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSSOVER TRIAL OF FLUNARIZINE IN COMMON MIGRAINE
    SORENSEN, PS
    HANSEN, K
    OLESEN, J
    CEPHALALGIA, 1986, 6 (01) : 7 - 14
  • [22] Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: A double-blind, randomised, placebo-controlled clinical trial
    Dodd, S.
    Berk, M.
    D'Souza, R.
    Hustig, H.
    Koopowitz, L.
    Monkhouse, A.
    Bole, F.
    Sathiya, S.
    Piskulic, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 139 - 140
  • [23] A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
    Stocchi, Fabrizio
    Borgohain, Rupam
    Onofrj, Marco
    Schapira, Anthony H. V.
    Bhatt, Mohit
    Lucini, Valentina
    Giuliani, Rodolfo
    Anand, Ravi
    MOVEMENT DISORDERS, 2012, 27 (01) : 106 - 112
  • [24] Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures
    Shorvon, SD
    Löwenthal, A
    Janz, D
    Bielen, E
    Loiseau, P
    EPILEPSIA, 2000, 41 (09) : 1179 - 1186
  • [25] Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
    Bakhshi, Sameer
    Batra, Atul
    Biswas, Bivas
    Dhawan, Deepa
    Paul, Reeja
    Sreenivas, Vishnubhatla
    SUPPORTIVE CARE IN CANCER, 2015, 23 (11) : 3229 - 3237
  • [26] Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial
    Berk, Michael
    Gama, Clarissa S.
    Sundram, Suresh
    Hustig, Harry
    Koopowitz, Les
    D'Souza, Russell
    Malloy, Hamish
    Rowland, Cate
    Monkhouse, Alison
    Monkhouse, Andrew
    Bole, Fiona
    Sathiyamoorthy, Sumathy
    Piskulic, Danijela
    Dodd, Seetal
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (03) : 233 - 238
  • [27] Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
    Sameer Bakhshi
    Atul Batra
    Bivas Biswas
    Deepa Dhawan
    Reeja Paul
    Vishnubhatla Sreenivas
    Supportive Care in Cancer, 2015, 23 : 3229 - 3237
  • [28] Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Chieh-Hsin
    Chang, Yue-Cune
    Lane, Hsien-Yuan
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 196 - 196
  • [29] A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia
    Weizman, Shira
    Shelef, Assaf
    Bloemhof Bris, Esther
    Stryjer, Rafael
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (06) : 629 - 631
  • [30] Allopurinol as adjunctive therapy in intractable epilepsy: A double-blind and placebo-controlled trial
    Togha, Mansoureh
    Akhondzadeh, Shahin
    Motamedi, Mahmood
    Ahmadi, Babak
    Razeghi, Soodeh
    ARCHIVES OF MEDICAL RESEARCH, 2007, 38 (03) : 313 - 316
12345